Pharmafile Logo
Pharmafocus logo
Advanced Search
document-428331_960_720

CSO loses position at DNA sequencing company after admitting fraud

February 23, 2017
Medical Communications Karmagenes

Pranav Ullal, formerly of Chief Scientific officer of Karmagenes, has been removed from his position after a paper he published …

News
pfizer_brussels

Pfizer’s Remicade biosimilar displays similar efficacy

February 22, 2017
Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …

News

Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims

February 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …

Feature
roche__tree

Roche and Discuva extend agreement to develop target antimicrobials

February 22, 2017
Research and Development, Sales and Marketing Discuva, Roche

Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …

News
8224204466_e6b23e80e6_z

Rabbit virus proves effective in treatment of multiple myeloma

February 22, 2017
Research and Development multiple myeloma

A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …

News
old_man_stick

Testosterone gel trials reveal mixed results of benefits and drawbacks

February 22, 2017
Research and Development Testosterone gel, testosterone

A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …

News
headshot_ryan

Nativis bolsters boardroom with new director

February 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …

Appointment
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

News

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017
Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …

News
naloxone

FDA rejects Amphastar’s application for NDA for intranasal overdose treatment

February 21, 2017
Research and Development Amphastar, FDA

Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …

News
aging_-_hand

Anti-aging study reveals role of mitochondria pointing towards new medicine

February 21, 2017
Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria

A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …

News

NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx

February 21, 2017
Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen

NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …

News
takeda

Faulty batch of Takeda’s paracetamol discovered in Denmark

February 21, 2017
Manufacturing and Production Denmark, Takeda

Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …

News
mr058666-web

Merck eyes new India bio-production facility

February 21, 2017
Manufacturing and Production Merck

German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …

News
handshake

Amygdala acquires Gilead’s candidate for addiction treatment

February 20, 2017
Manufacturing and Production, Sales and Marketing Amygdala, Gilead

Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …

News

BlackThorn Therapeutics bring in new CEO

February 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …

Appointment
medication

Generic version of top-selling lung cancer drug hits Chinese market

February 20, 2017
Sales and Marketing China, generics

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …

News
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017
Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …

News
heart_image

Cardiovascular disease expected to place $1 trillion cost burden on US

February 20, 2017
Medical Communications, Sales and Marketing cardiovascular disease

A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …

News
astrazeneca_logo_building

AstraZeneca sells off cancer drug to TerSera for $250 million

February 20, 2017
Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex

AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026